LANDMARK INVEST AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−750 kr).

LANDMARK INVEST AS is registered as a limited company in Oslo, Oslo with organisation number 928773744. The business is classified under rental and operating of own or leased real estate (NACE 68.200). The company was incorporated in 2022. Registered share capital is NOK 50,000, divided into 1000 shares. The company's stated purpose is: “Konsulenttjenester, investering i fast eiendom og finansielle aktiva, herunder i selskaper med tilsvarende formål.”.

Key figures · 2025

Operating profit

NOK −750

▲ +0 %

Equity

NOK 31,000

▼ −2 %

Est. value

NOK 28,000

Financial health · 2025

Liquidity

4.99

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

1.7%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns LANDMARK INVEST AS?

Thomas Ankarloo Landmark Private shareholder

80.0%

Tria Marie Garcia Landmark Private shareholder

20.0%

LANDMARK INVEST AS

· NOK −750 profit

LANDMARK INVEST AS has 2 registered shareholders:

• Thomas Ankarloo Landmark 80.0%
• Tria Marie Garcia Landmark 20.0%

All shareholders and roles →

Which companies does LANDMARK INVEST AS own?

LANDMARK INVEST AS holds stakes in 3 companies:

• NETTBUTIKKER AS 50.0%
• IMMUNOPHARMA AS 0.3%
• MYCOTECH PHARMA AS 0.0%

See the full ownership structure →

Frequently asked questions about LANDMARK INVEST AS

Who owns LANDMARK INVEST AS?

Thomas Ankarloo Landmark is the largest registered owner, with 80.0%.

Where is LANDMARK INVEST AS based?

LANDMARK INVEST AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.